Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

l-Arabinose triggers its own uptake via induction of the arabinose-specific Gal2p transporter in an industrial Saccharomyces cerevisiae strain.

Oehling V, Klaassen P, Frick O, Dusny C, Schmid A.

Biotechnol Biofuels. 2018 Aug 23;11:231. doi: 10.1186/s13068-018-1231-8. eCollection 2018.

2.

Risk Factors for Necrotizing Enterocolitis: A Prospective Multicenter Case-Control Study.

Berkhout DJC, Klaassen P, Niemarkt HJ, de Boode WP, Cossey V, van Goudoever JB, Hulzebos CV, Andriessen P, van Kaam AH, Kramer BW, van Lingen RA, Vijlbrief DC, van Weissenbruch MM, Benninga M, de Boer NKH, de Meij TGJ.

Neonatology. 2018;114(3):277-284. doi: 10.1159/000489677. Epub 2018 Jul 11.

3.

The Penicillium chrysogenum transporter PcAraT enables high-affinity, glucose-insensitive l-arabinose transport in Saccharomyces cerevisiae.

Bracher JM, Verhoeven MD, Wisselink HW, Crimi B, Nijland JG, Driessen AJM, Klaassen P, van Maris AJA, Daran JG, Pronk JT.

Biotechnol Biofuels. 2018 Mar 13;11:63. doi: 10.1186/s13068-018-1047-6. eCollection 2018.

4.

A parsec-scale optical jet from a massive young star in the Large Magellanic Cloud.

McLeod AF, Reiter M, Kuiper R, Klaassen PD, Evans CJ.

Nature. 2018 Feb 15;554(7692):334-336. doi: 10.1038/nature25189. Epub 2018 Jan 24.

PMID:
29364870
5.

Increased xylose affinity of Hxt2 through gene shuffling of hexose transporters in Saccharomyces cerevisiae.

Nijland JG, Shin HY, de Waal PP, Klaassen P, Driessen AJM.

J Appl Microbiol. 2018 Feb;124(2):503-510. doi: 10.1111/jam.13670.

PMID:
29240974
6.

Saccharomyces cerevisiae strains for second-generation ethanol production: from academic exploration to industrial implementation.

Jansen MLA, Bracher JM, Papapetridis I, Verhoeven MD, de Bruijn H, de Waal PP, van Maris AJA, Klaassen P, Pronk JT.

FEMS Yeast Res. 2017 Aug 1;17(5). doi: 10.1093/femsyr/fox044. Review.

7.

Improved Xylose Metabolism by a CYC8 Mutant of Saccharomyces cerevisiae.

Nijland JG, Shin HY, Boender LGM, de Waal PP, Klaassen P, Driessen AJM.

Appl Environ Microbiol. 2017 May 17;83(11). pii: e00095-17. doi: 10.1128/AEM.00095-17. Print 2017 Jun 1.

8.

The winds from HL Tau.

Klaassen PD, Mottram JC, Maud LT, Juhasz A.

Mon Not R Astron Soc. 2016 Apr 28;460(1):627-633. eCollection 2016 Jul 21.

9.

Improving pentose fermentation by preventing ubiquitination of hexose transporters in Saccharomyces cerevisiae.

Nijland JG, Vos E, Shin HY, de Waal PP, Klaassen P, Driessen AJ.

Biotechnol Biofuels. 2016 Jul 26;9:158. doi: 10.1186/s13068-016-0573-3. eCollection 2016.

10.

Explaining the variable penetrance of CNVs: Parental intelligence modulates expression of intellectual impairment caused by the 22q11.2 deletion.

Klaassen P, Duijff S, Swanenburg de Veye H, Beemer F, Sinnema G, Breetvelt E, Schappin R, Vorstman J.

Am J Med Genet B Neuropsychiatr Genet. 2016 Sep;171(6):790-6. doi: 10.1002/ajmg.b.32441. Epub 2016 Mar 8.

PMID:
26953189
11.

An engineered cryptic Hxt11 sugar transporter facilitates glucose-xylose co-consumption in Saccharomyces cerevisiae.

Shin HY, Nijland JG, de Waal PP, de Jong RM, Klaassen P, Driessen AJ.

Biotechnol Biofuels. 2015 Nov 2;8:176. doi: 10.1186/s13068-015-0360-6. eCollection 2015.

12.

Cognitive decline preceding the onset of psychosis in patients with 22q11.2 deletion syndrome.

Vorstman JA, Breetvelt EJ, Duijff SN, Eliez S, Schneider M, Jalbrzikowski M, Armando M, Vicari S, Shashi V, Hooper SR, Chow EW, Fung WL, Butcher NJ, Young DA, McDonald-McGinn DM, Vogels A, van Amelsvoort T, Gothelf D, Weinberger R, Weizman A, Klaassen PW, Koops S, Kates WR, Antshel KM, Simon TJ, Ousley OY, Swillen A, Gur RE, Bearden CE, Kahn RS, Bassett AS; International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome.

JAMA Psychiatry. 2015 Apr;72(4):377-85. doi: 10.1001/jamapsychiatry.2014.2671.

13.

Intellectual functioning in relation to autism and ADHD symptomatology in children and adolescents with 22q11.2 deletion syndrome.

Hidding E, Swaab H, de Sonneville LM, van Engeland H, Sijmens-Morcus ME, Klaassen PW, Duijff SN, Vorstman JA.

J Intellect Disabil Res. 2015 Sep;59(9):803-15. doi: 10.1111/jir.12187. Epub 2015 Feb 13.

PMID:
25683771
14.

Engineering of an endogenous hexose transporter into a specific D-xylose transporter facilitates glucose-xylose co-consumption in Saccharomyces cerevisiae.

Nijland JG, Shin HY, de Jong RM, de Waal PP, Klaassen P, Driessen AJ.

Biotechnol Biofuels. 2014 Nov 29;7(1):168. doi: 10.1186/s13068-014-0168-9. eCollection 2014.

15.

Behavioral phenotype in children with 22q11DS: agreement between parents and teachers.

Klaassen PW, Duijff SN, Sinnema G, Beemer FA, Swanenburg de Veye HF, Vorstman JA.

Psychol Assess. 2015 Mar;27(1):272-9. doi: 10.1037/a0038102. Epub 2014 Dec 1.

PMID:
25436664
16.

Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome.

Schneider M, Debbané M, Bassett AS, Chow EW, Fung WL, van den Bree M, Owen M, Murphy KC, Niarchou M, Kates WR, Antshel KM, Fremont W, McDonald-McGinn DM, Gur RE, Zackai EH, Vorstman J, Duijff SN, Klaassen PW, Swillen A, Gothelf D, Green T, Weizman A, Van Amelsvoort T, Evers L, Boot E, Shashi V, Hooper SR, Bearden CE, Jalbrzikowski M, Armando M, Vicari S, Murphy DG, Ousley O, Campbell LE, Simon TJ, Eliez S; International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome.

Am J Psychiatry. 2014 Jun;171(6):627-39. Review.

17.

Cognitive and behavioral trajectories in 22q11DS from childhood into adolescence: a prospective 6-year follow-up study.

Duijff SN, Klaassen PW, Swanenburg de Veye HF, Beemer FA, Sinnema G, Vorstman JA.

Res Dev Disabil. 2013 Sep;34(9):2937-45. doi: 10.1016/j.ridd.2013.06.001. Epub 2013 Jun 29.

PMID:
23816629
18.

Enhanced maternal origin of the 22q11.2 deletion in velocardiofacial and DiGeorge syndromes.

Delio M, Guo T, McDonald-McGinn DM, Zackai E, Herman S, Kaminetzky M, Higgins AM, Coleman K, Chow C, Jalbrzikowski M, Bearden CE, Bailey A, Vangkilde A, Olsen L, Olesen C, Skovby F, Werge TM, Templin L, Busa T, Philip N, Swillen A, Vermeesch JR, Devriendt K, Schneider M, Dahoun S, Eliez S, Schoch K, Hooper SR, Shashi V, Samanich J, Marion R, van Amelsvoort T, Boot E, Klaassen P, Duijff SN, Vorstman J, Yuen T, Silversides C, Chow E, Bassett A, Frisch A, Weizman A, Gothelf D, Niarchou M, van den Bree M, Owen MJ, Suñer DH, Andreo JR, Armando M, Vicari S, Digilio MC, Auton A, Kates WR, Wang T, Shprintzen RJ, Emanuel BS, Morrow BE.

Am J Hum Genet. 2013 Mar 7;92(3):439-47. doi: 10.1016/j.ajhg.2013.01.018. Epub 2013 Feb 28. Erratum in: Am J Hum Genet. 2013 Apr 4;92(4):637. Jarlbrzkowski, Maria [corrected to Jalbrzikowski, Maria].

19.

Behavior in preschool children with the 22q11.2 deletion syndrome.

Klaassen P, Duijff S, Swanenburg de Veye H, Vorstman J, Beemer F, Sinnema G.

Am J Med Genet A. 2013 Jan;161A(1):94-101. doi: 10.1002/ajmg.a.35685. Epub 2012 Dec 13.

PMID:
23239609
20.

Searching for microbial protein over-expression in a complex matrix using automated high throughput MS-based proteomics tools.

Akeroyd M, Olsthoorn M, Gerritsma J, Gutker-Vermaas D, Ekkelkamp L, van Rij T, Klaassen P, Plugge W, Smit E, Strupat K, Wenzel T, van Tilborg M, van der Hoeven R.

J Biotechnol. 2013 Mar 10;164(1):112-20. doi: 10.1016/j.jbiotec.2012.11.015. Epub 2012 Dec 5.

PMID:
23220267
21.

[Doege-Potter syndrome: hypoglycemia secondary to solitary fibrous tumor of the pleura. Report of one case].

Campos M R, González L R, Saldías F R, Klaassen P R, Alarcón C E.

Rev Med Chil. 2012 Mar;140(3):353-7. doi: 10.4067/S0034-98872012000300011. Spanish.

22.

Cognitive development in children with 22q11.2 deletion syndrome.

Duijff SN, Klaassen PW, de Veye HF, Beemer FA, Sinnema G, Vorstman JA.

Br J Psychiatry. 2012 Jun;200(6):462-8. doi: 10.1192/bjp.bp.111.097139.

PMID:
22661678
23.

De novo sequencing, assembly and analysis of the genome of the laboratory strain Saccharomyces cerevisiae CEN.PK113-7D, a model for modern industrial biotechnology.

Nijkamp JF, van den Broek M, Datema E, de Kok S, Bosman L, Luttik MA, Daran-Lapujade P, Vongsangnak W, Nielsen J, Heijne WH, Klaassen P, Paddon CJ, Platt D, Kötter P, van Ham RC, Reinders MJ, Pronk JT, de Ridder D, Daran JM.

Microb Cell Fact. 2012 Mar 26;11:36. doi: 10.1186/1475-2859-11-36.

24.

Intelligence and visual motor integration in 5-year-old children with 22q11-deletion syndrome.

Duijff S, Klaassen P, Beemer F, Swanenburg de Veye H, Vorstman J, Sinnema G.

Res Dev Disabil. 2012 Mar-Apr;33(2):334-40. doi: 10.1016/j.ridd.2011.10.004. Epub 2011 Nov 24.

PMID:
22119678
25.

Degeneration of penicillin production in ethanol-limited chemostat cultivations of Penicillium chrysogenum: A systems biology approach.

Douma RD, Batista JM, Touw KM, Kiel JA, Krikken AM, Zhao Z, Veiga T, Klaassen P, Bovenberg RA, Daran JM, Heijnen JJ, van Gulik WM.

BMC Syst Biol. 2011 Aug 19;5:132. doi: 10.1186/1752-0509-5-132.

26.

Exploring and dissecting genome-wide gene expression responses of Penicillium chrysogenum to phenylacetic acid consumption and penicillinG production.

Harris DM, van der Krogt ZA, Klaassen P, Raamsdonk LM, Hage S, van den Berg MA, Bovenberg RA, Pronk JT, Daran JM.

BMC Genomics. 2009 Feb 10;10:75. doi: 10.1186/1471-2164-10-75.

27.

Comparison of outcomes in high-risk patients>70 years of age with aortic valvuloplasty and percutaneous coronary intervention versus aortic valvuloplasty alone.

Pedersen WR, Klaassen PJ, Pedersen CW, Wilson JA, Harris KM, Goldenberg IF, Poulose AK, Mooney MR, Henry TD, Schwartz RS.

Am J Cardiol. 2008 May 1;101(9):1309-14. doi: 10.1016/j.amjcard.2007.12.033. Epub 2008 Mar 17.

PMID:
18435963
28.

Production of functionally active Penicillium chrysogenum isopenicillin N synthase in the yeast Hansenula polymorpha.

Gidijala L, Bovenberg RA, Klaassen P, van der Klei IJ, Veenhuis M, Kiel JA.

BMC Biotechnol. 2008 Mar 19;8:29. doi: 10.1186/1472-6750-8-29.

29.

Feasibility of transcatheter intervention for severe aortic stenosis in patients >or=90 years of age: aortic valvuloplasty revisited.

Pedersen WR, Klaassen PJ, Boisjolie CR, Pierce TA, Harris KM, Lesser JR, Hara H, Mooney MR, Graham KJ, Kshettry VR, Goldenberg IF, Priztker MR, Van Tassel RA, Schwartz RS.

Catheter Cardiovasc Interv. 2007 Jul 1;70(1):149-54.

PMID:
17503515
30.

A piece of my mind. What makes a difference.

Klaassen PA.

JAMA. 2007 Mar 14;297(10):1039. No abstract available.

PMID:
17356018
31.

Behavioral problems in relation to intelligence in children with 22q11.2 deletion syndrome: a matched control study.

Jansen PW, Duijff SN, Beemer FA, Vorstman JA, Klaassen PW, Morcus ME, Heineman-de Boer JA.

Am J Med Genet A. 2007 Mar 15;143A(6):574-80.

PMID:
17318841
32.

The 22q11.2 deletion in children: high rate of autistic disorders and early onset of psychotic symptoms.

Vorstman JAS, Morcus MEJ, Duijff SN, Klaassen PWJ, Heineman-de Boer JA, Beemer FA, Swaab H, Kahn RS, van Engeland H.

J Am Acad Child Adolesc Psychiatry. 2006 Sep;45(9):1104-1113. doi: 10.1097/01.chi.0000228131.56956.c1.

PMID:
16926618
33.

How are you doing?

Klaassen P.

Fam Pract Manag. 2006 Feb;13(2):22. No abstract available.

34.

Glucose uptake kinetics and transcription of HXT genes in chemostat cultures of Saccharomyces cerevisiae.

Diderich JA, Schepper M, van Hoek P, Luttik MA, van Dijken JP, Pronk JT, Klaassen P, Boelens HF, de Mattos MJ, van Dam K, Kruckeberg AL.

J Biol Chem. 1999 May 28;274(22):15350-9.

35.

Contribution of the individual HXT gene products to CO2 production.

Klaassen P, Raamsdonk L.

Folia Microbiol (Praha). 1998;43(2):197-200. No abstract available.

PMID:
9721611
36.

Customer service trumps regulations.

Klaassen PJ.

Contemp Longterm Care. 1998 Apr;21(4):92, 94. No abstract available.

PMID:
10178950
37.

Never say downscale. Assisted living may be more affordable than you think.

Klaassen PJ.

Contemp Longterm Care. 1997 May;20(5):34-5. No abstract available.

PMID:
10167543
38.

Use of a yeast strain expressing glucoamylase in malt whisky fermentations.

Klaassen P, van den Bos AP, van Rooijen RJ, Plomp PJ.

Folia Microbiol (Praha). 1996;41(1):100-1. No abstract available.

PMID:
9090840
39.

Effects of the NTH1 gene disruption in bakers' yeast.

Klaassen P, Blankwater YJ, van Marrewijk LP, Osinga KA, Baankreis R.

Folia Microbiol (Praha). 1994;39(6):524-6. No abstract available.

PMID:
8550012
40.
41.

Increased importance placed on resident-centered design.

Klaassen P.

Provider. 1990 Oct;16(10):43-4. No abstract available.

PMID:
10107238
42.

Structural organization of the human androgen receptor gene.

Kuiper GG, Faber PW, van Rooij HC, van der Korput JA, Ris-Stalpers C, Klaassen P, Trapman J, Brinkmann AO.

J Mol Endocrinol. 1989 May;2(3):R1-4.

PMID:
2546571
43.

The prostate-specific antigen gene and the human glandular kallikrein-1 gene are tandemly located on chromosome 19.

Riegman PH, Vlietstra RJ, Klaassen P, van der Korput JA, Geurts van Kessel A, Romijn JC, Trapman J.

FEBS Lett. 1989 Apr 10;247(1):123-6.

44.

Oncogene expression in Rauscher murine leukemia virus induced erythroid, myeloid and lymphoid cell lines.

de Both NJ, van der Feltz MJ, Mooren A, Vermaas D, Klaassen P, Rhijnsburger EH, Kranendonk-Odijk ME.

Leuk Res. 1989;13(1):53-64.

PMID:
2915575
45.

The human androgen receptor: domain structure, genomic organization and regulation of expression.

Brinkmann AO, Faber PW, van Rooij HC, Kuiper GG, Ris C, Klaassen P, van der Korput JA, Voorhorst MM, van Laar JH, Mulder E, et al.

J Steroid Biochem. 1989;34(1-6):307-10.

PMID:
2626022
46.

Molecular cloning and characterization of novel prostate antigen cDNA's.

Riegman PH, Klaassen P, van der Korput JA, Romijn JC, Trapman J.

Biochem Biophys Res Commun. 1988 Aug 30;155(1):181-8.

PMID:
2458104
47.

Cloning, structure and expression of a cDNA encoding the human androgen receptor.

Trapman J, Klaassen P, Kuiper GG, van der Korput JA, Faber PW, van Rooij HC, Geurts van Kessel A, Voorhorst MM, Mulder E, Brinkmann AO.

Biochem Biophys Res Commun. 1988 May 31;153(1):241-8.

PMID:
3377788
48.

[The effect of a dentifrice containing pyrophosphates on calculus accumulation].

van der Burgt TP, Klaassen PP.

Ned Tijdschr Tandheelkd. 1988 Mar;95(3):108-11. Dutch. No abstract available.

PMID:
2855882
49.

Structure-function analysis of murine interferon-alpha: antiviral properties of novel hybrid interferons.

Van Heuvel M, Bosveld IJ, Klaassen P, Zwarthoff EC, Trapman J.

J Interferon Res. 1988 Feb;8(1):5-14.

PMID:
3367062
50.

Effects of FSH and IGF-I on immature rat Sertoli cells: inhibin alpha- and beta-subunit mRNA levels and inhibin secretion.

Toebosch AM, Robertson DM, Trapman J, Klaassen P, de Paus RA, de Jong FH, Grootegoed JA.

Mol Cell Endocrinol. 1988 Jan;55(1):101-5.

PMID:
3129322

Supplemental Content

Loading ...
Support Center